Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
Ying Li et al.
FRONTIERS IN ONCOLOGY (2021)
Pancancer survival analysis of cancer hallmark genes
Adam Nagy et al.
SCIENTIFIC REPORTS (2021)
Lovastatin Inhibits EMT and Metastasis of Triple-Negative Breast Cancer Stem Cells Through Dysregulation of Cytoskeleton-Associated Proteins
Chanjuan Zheng et al.
FRONTIERS IN ONCOLOGY (2021)
Update on systemic treatment in early triple negative breast cancer
Martin Nunez Abad et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2021)
TIMER2.0 for analysis of tumor-infiltrating immune cells
Taiwen Li et al.
NUCLEIC ACIDS RESEARCH (2020)
Identification of Novel Prognosis and Prediction Markers in Advanced Prostate Cancer Tissues Based on Quantitative Proteomics
Oh Kwang Kwon et al.
CANCER GENOMICS & PROTEOMICS (2020)
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2019)
Clinical and Therapeutic Implications of Cancer Stem Cells
Michael F. Clarke
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Therapeutic Approaches Targeting Nucleolus in Cancer
Pietro Carotenuto et al.
CELLS (2019)
Ribosome biogenesis: An emerging druggable pathway for cancer therapeutics
Frederic Catez et al.
BIOCHEMICAL PHARMACOLOGY (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
Alice Lee et al.
CANCER TREATMENT REVIEWS (2018)
Nucleolar TRF2 attenuated nucleolus stress-induced HCC cell-cycle arrest by altering rRNA synthesis
Fuwen Yuan et al.
CELL DEATH & DISEASE (2018)
Nucleolar stress: is there a reverse version?
Lu Lu et al.
JOURNAL OF CANCER (2018)
Lovastatin Inhibits Cancer Stem Cells and Sensitizes to Chemo- and Photodynamic Therapy in Nasopharyngeal Carcinoma
Yikun Peng et al.
JOURNAL OF CANCER (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
Enhanced NOLC1 promotes cell senescence and represses hepatocellular carcinoma cell proliferation by disturbing the organization of nucleolus
Fuwen Yuan et al.
AGING CELL (2017)
Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells
Tomonori Tanei et al.
BREAST CANCER RESEARCH (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
Cell-fate determination by ubiquitin-dependent regulation of translation
Achim Werner et al.
NATURE (2015)
Nucleostemin Knockdown Sensitizes Hepatocellular Carcinoma Cells to Ultraviolet and Serum Starvation-Induced Apoptosis
Fuwen Yuan et al.
PLOS ONE (2015)
Breast cancer stem cells: Multiple capacities in tumor metastasis
Shao-Qing Geng et al.
CANCER LETTERS (2014)
GenomeRNAi: a database for cell-based and in vivo RNAi phenotypes, 2013 update
Esther E. Schmidt et al.
NUCLEIC ACIDS RESEARCH (2013)
Methylation of nucleolar and coiled-body phosphoprotein 1 is associated with the mechanism of tumorigenesis in hepatocellular carcinoma
Xuefei Duan et al.
ONCOLOGY REPORTS (2013)
CD44+/CD24-/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome
Michael O. Idowu et al.
HUMAN PATHOLOGY (2012)
Revisiting the Nucleolus: From Marker to Dynamic Integrator of Cancer Signaling
Davide Ruggero
SCIENCE SIGNALING (2012)
Identification of nucleolar and coiled-body phosphoprotein 1 (NOLC1) minimal promoter regulated by NF-κB and CREB
Xuesong Gao et al.
BMB REPORTS (2011)
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
Sunil Badve et al.
MODERN PATHOLOGY (2011)
NOLC1, an Enhancer of Nasopharyngeal Carcinoma Progression, Is Essential for TP53 to Regulate MDM2 Expression
Yu-Chyi Hwang et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
PrognoScan: a new database for meta-analysis of the prognostic value of genes
Hideaki Mizuno et al.
BMC MEDICAL GENOMICS (2009)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
Daniel R. Rhodes et al.
NEOPLASIA (2007)
Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis:: a cohort study
Per Hall et al.
BMC MEDICINE (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Y Pawitan et al.
BREAST CANCER RESEARCH (2005)
Share Paper
